Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
February 12, 2011
Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study
S Lecleire, M Antonietti, I Iwanicki-Caron, et al.
Oral Oncology
|
May 22, 2019
Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma
A Rambeau, V Bastit, S Thureau, et al.
Alimentary Pharmacology & Therapeutics
|
April 4, 2007
Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity
S Lecleire, M Antonietti, F Di Fiore, et al.
Neuro-Chirurgie
|
March 4, 2023
Impact of Covid-19 pandemic on neuro-oncology multidisciplinary tumor board in the pre-vaccine era: the Normandy experience
M Lacaud, A Leclerc, F Marguet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 7, 2015
Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients
L Lefebvre, E Noyon, D Georgescu, et al.
ESMO Open
|
December 25, 2022
Impact of EGFR<sup>A289T/V</sup> mutation on relapse pattern in glioblastoma
A Noeuveglise, N Sarafan-Vasseur, L Beaussire, et al.
Revue Neurologique
|
July 23, 2022
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma
M Fontanilles, A Deniel, F Marguet, et al.
British Journal of Cancer
|
September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
P Michel, A Adenis, F Di Fiore, et al.
British Journal of Cancer
|
April 16, 2009
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
A Oden-Gangloff, F Di Fiore, F Bibeau, et al.
British Journal of Cancer
|
March 22, 2007
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
F Di Fiore, F Blanchard, F Charbonnier, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
February 12, 2011
Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study
S Lecleire, M Antonietti, I Iwanicki-Caron, et al.
Oral Oncology
|
May 22, 2019
Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma
A Rambeau, V Bastit, S Thureau, et al.
Alimentary Pharmacology & Therapeutics
|
April 4, 2007
Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity
S Lecleire, M Antonietti, F Di Fiore, et al.
Neuro-Chirurgie
|
March 4, 2023
Impact of Covid-19 pandemic on neuro-oncology multidisciplinary tumor board in the pre-vaccine era: the Normandy experience
M Lacaud, A Leclerc, F Marguet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
September 7, 2015
Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients
L Lefebvre, E Noyon, D Georgescu, et al.
ESMO Open
|
December 25, 2022
Impact of EGFR<sup>A289T/V</sup> mutation on relapse pattern in glioblastoma
A Noeuveglise, N Sarafan-Vasseur, L Beaussire, et al.
Revue Neurologique
|
July 23, 2022
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma
M Fontanilles, A Deniel, F Marguet, et al.
British Journal of Cancer
|
September 13, 2006
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
P Michel, A Adenis, F Di Fiore, et al.
British Journal of Cancer
|
April 16, 2009
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
A Oden-Gangloff, F Di Fiore, F Bibeau, et al.
British Journal of Cancer
|
March 22, 2007
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
F Di Fiore, F Blanchard, F Charbonnier, et al.
Page
of 4